Immune modulation after total hip surgery: A prospective ex vivo study

European Surgical Research

Volumn 39, Issue 5, 2007, Pages 296-302

  Bastian, D ^a   Sun, J ^b   Danckert Krohn, C ^a   Reikeras O ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Immune response; Interleukin 6; Orthopedic trauma; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CYTOKINE RELEASE; DATA ANALYSIS; FEMALE; HUMAN; IMMUNOMODULATION; LEUKOCYTE COUNT; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; TOTAL HIP PROSTHESIS;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-6; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548071982     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104400     Document Type: Article

References (43)

1. Hassett S, Moynagh P, Reen D: TNF-α is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome. Pediatr Surg Int 2006;22:24-30.
2. Astiz M, Saha D, Lustbader D, Lin R, Rackow E: Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996;128:594-600.
3. Kelly JL, O'Sullivan C, O'Riordain M, O'Riordain D, Lyons A, Doherty J, Mannick JA, Rodrick ML: Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg 1997;225:530-541.
4. Dimofte G, Alexander A, Carlson G, Little R, Irving M: TNF-α and IL-6 involvement in surgical trauma. II. In vitro cytokine production. Rev Med Chir Soc Med Nat Iasi 2001;105:493-498.
5. Keel M, Trentz O: Pathophysiology of polytrauma. Injury 2005;36:691-709.
6. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-1347.
7. Reikeraas O, Sun J, Krohn CD, Wang JE, Aasen AO: Reduced capacity of whole blood leucocytes to express tumour necrosis factor-α and interleukin-10 following major orthopaedic surgery. Eur Surg Res 2005;37:210-215.
8. Hermann C, von AS, Dehus O, Keller M, Okigami H, Gantner F, Wendel A, Hartung T: Endogenous cortisol determines the circadian rhythm of lipopolysaccharide - but not lipoteichoic acid-inducible cytokine release. Eur J Immunol 2006;36:371-379.
9. Wang JE, Solberg R, Okkenhaug C, Jorgensen PF, Krohn CD, Aasen AO: Cytokine modulation in experimental endotoxemia: characterization of an ex vivo whole blood model. Eur Surg Res 2000;32:65-73.
10. Wang JE, Warris A, Ellingsen EA, Jorgensen PF, Flo TH, Espevik T, Solberg R, Verweij PE, Aasen AO: Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 2001;69:2402-2406.
11. Rotstein OD: Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma 2003;54(suppl):S203- S206.
12. Dinarello CA: Proinflammatory cytokines. Chest 2000;118:503-508.
13. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
14. Van Griensven M, Krettek C, Pape HC: Immune reactions after trauma. Eur J Trauma 2003;29:181-192.
15. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996;224:647-664.
16. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin-1, -2, and -6 and tumor necrosis factor-α in multiple trauma patients. J Trauma 1994;36:336-340.
17. Foex BA, Lamb WR, Roberts TE, Brear SG, Macartney I, Hammer M, Brenchley PE: Early cytokine response to multiple injury. Injury 1993;24:373-376.
18. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G: Serum tumor necrosis factor-α profile in trauma patients. J Trauma 1993;35:698-702.
19. Marano MA, Moldawer LL, Fong Y, Wei H, Minei J, Yurt R, Cerami A, Lowry SF: Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch Surg 1988;123:1383-1388.
20. Drost AC, Burleson DG, Cioffi WG Jr, Mason AD Jr, Pruitt BA Jr: Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993;218:74-78.
21. Yamada Y, Endo S, Inada K: Plasma cytokine levels in patients with severe burn injury - with reference to the relationship between infection and prognosis. Burns 1996;22:587-593.
22. Vindenes HA, Ulvestad E, Bjerknes R: Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg 1998;164:647-656.
23. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R: Efficacy and safety of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-α MAb Sepsis Study Group. JAMA 1995;273:934-941.
24. Reinhart K, Wiegand-Lohnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 1996;24:733-742.
25. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-77.
26. Nagata S: Apoptosis by death factor. Cell 1997;88:355-365.
27. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-1128.
28. Menger MD, Vollmar B: Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 2004;389:475-484.
29. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 as an anti-inflammatory cytokine: induction of circulating interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-118.
30. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
31. Smail N, Messiah A, Edouard A, Scorps-Declere A, Duranteau J, Vigue B, Mimoz O, Samii K: Role of systemic inflammatory response syndrome and infection in the occurrence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med 1995;21:813-816.
32. Waydhas C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, Schweiberer L, Jochum M: Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 1996;40:624-630.
33. Wichmann MW, Ayala A, Chaudry IH: Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 1998;26:1372-1378.
34. Kong SE, Blennerhassett LR, Heel KA, McCauley RD, Hall JC: Ischaemia-reperfusion injury to the intestine. Aust NZ J Surg 1998;68:554-561.
35. Moore FA: The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 1999;178:449-453.
36. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778.
37. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481-1486.
38. West MA, Heagy W: Endotoxin tolerance: a review. Crit Care Med 2002;30(suppl):S64-S73.
39. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
40. Brandtzaeg P, Osnes L, Ovstebo R, Joo GB, Westvik AB, Kierulf P: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 1996;184:51-60.
41. Badger AM, Olivera DL, Esser KM: Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock 1994;44:188-195.
42. Van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-6 production in human whole blood. Infect Immun 1994;62:2046-2050.
43. Schroder O, Laun RA, Held B, Ekkernkamp A, Schulte KM: Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock 2004;21:306-310.